Legal Representation
Attorney
Kevin W. King
USPTO Deadlines
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 7, 2025 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Jul 7, 2025 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Jul 7, 2025 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Jul 6, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jan 29, 2025 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Sep 3, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 1, 2024 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Apr 5, 2023 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jan 25, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 25, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 25, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 25, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jan 25, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 5, 2021 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Nov 5, 2021 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Nov 5, 2021 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Oct 1, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 1, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 1, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 2, 2021 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Sep 1, 2020 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Apr 5, 2017 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 5, 2017 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 1, 2015 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 28, 2015 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jul 27, 2015 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 3, 2015 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jun 23, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 27, 2015 | IUAF | S | USE AMENDMENT FILED | Loading... |
| May 27, 2015 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 3, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 9, 2014 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 9, 2014 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 19, 2014 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 5, 2014 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 5, 2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 5, 2014 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 18, 2014 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Sep 9, 2014 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 8, 2014 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 8, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 2, 2014 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Aug 28, 2014 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and occular allergy; pharmaceutical preparations for the treatment of macular edema, macular disease, retinal disease, glaucoma, and occular allergy
First Use Anywhere:
20140300
First Use in Commerce:
20140300
Class 010
Sustained drug delivery systems for ocular drugs
First Use Anywhere:
20140300
First Use in Commerce:
20140300
Additional Information
Design Mark
The mark consists of of the word "ILUVIEN" in blue with three horizontal lines in gold appearing above the second "I" and extending to the left in staggered lengths.
Color Claim
The color(s) blue and gold is/are claimed as a feature of the mark.
Classification
International Classes
005
010